Canada To Start Temporarily Reimbursing Drugs That Need More Evidence
Manufacturers participating in CADTH's new time-limited funding mechanism must submit updated clinical trial data within the agreed-upon time or their funding will be terminated and any existing patients will become their responsibility.
